To determine the basis for differences in interferons previously noted by others, we prepared five types of human interferon, namely interferon induced in muscle skin fibroblasts using complexed polyinosinic:polycytidylic acid (IC) and Newcastle disease virus (NDV), and interferon induced in leukocytes using IC, NDV, and phytohemagglutinin. We determined the molecular weight, isoelectric point, inactivation rate at 56°C and structural activity relationships for each interferon. Significant differences between these interferons were found, many of which seem related to the cell induced rather than the inducer. We believe these findings have important pharmacological implications for the use of interferon in man.
Recent investigations have established that human fibroblast interferon induced by complexed polyinosinic:polycytidylic acid (IC) is different from human leukocyte interferon induced by viruses (6, 9, 18, 20) . Dissimilarities between these two interferons have been found in their antigenicity (9) , in the circumstances under which they will renature (18) , and in their sensitivity to guanidine (6) and heat (20) . Although many issues remain unsolved, particularly pressing questions which are still unanswered include the following: which factors dictate when a given interferon will be elaborated; is there a molecular basis for the observed dissimilarities; and how many human interferons can be expected to exist? The answers to these questions may have particular relevance for identifying a human interferon species which will be pharmacologically superior for clinical application.
We addressed these questions by preparing five varieties of human interferon: interferon prepared in human fibroblasts (muscle skin fibroblast [MSF] purified preparations are possible. Nevertheless, since each of the interferons was studied under identical circumstances, the resulting data are clearly valid for comparing interferons and offer insight into the occasional differences among crude interferons that have been observed previously. Additionally, this information will be of value in deciding on purification schemes and ultimately in determining what alteration in native crude interferon (i.e., as it exists in its native state) are caused by a particular purification sequence. Indeed it has been possible to determine that the cell induced exerts an-important influence on the properties of the interferon secreted, that the circumstances of the induction may alter at least some of these properties, and that the observed differences appear to be associated with structural dissimilarities within the interferon molecule.
MATERIALS AND METHODS
Preparation of virus-, IC-, and PHA-induced human interferon in WBCs (WBC-NDV, WBC-IC, and WBC-PHA). After separation by low-speed centrifugation from blood acidified with ammonium chloride for 10 min, human white blood cells (WBCs) were washed twice with Leibovitz medium (L-15). The cells were subsequently suspended at a density of 10 million/ml in L-15 supplemented with 5% fetal calf serum (FCS) and rolled in test tubes for 18 h at 37°C in the presence of NDV (multiplicity of 100 median egg infectious dose [EID50] per cell) for preparation of WBC-NDV interferon. The interferon-containing medium was separated by pelleting the cells at lowspeed centrifugation and then sequentially dialyzed against 0.1 M citric acid at pH 2.7 for 5 days and phosphate-buffered saline (PBS) at pH 7.4 for 24 h.
After centrifugation at 25,000 rpm for 90 min in a Beckman SW27 rotor, 2-ml aliquots of the pooled interferon-containing supernatant were frozen at -80°C. For WBC-IC, the cells, at a similar concentration, were suspended in a solution of IC (10 ,ug ml) and diethylaminoethyl dextran (DEAE-D) (100 ,ug/ml) in PBS, rolled at 40C for 1 h, washed three times with supplemented L-15, and rolled at 37°C for a further 18 h. The interferon-containing medium was then separated from the cells by low-speed centrifugation, aliquoted, and stored as noted above.
For WBC-PHA, fresh human leukocytes as described above were incubated with a 1:400 dilution of phytohemagglutinin P (Difco) as 2.0-ml aliquots in tissue culture tubes rolled for 18 h at 370C. After centrifugation at 1,000 rpm for 10 min, the pooled supernatants were dialyzed in PBS (pH 7.4) for 24 h before freezing and storing at -80°C in 2.0-ml aliquots. Separate preparations of WBC-PHA were acid-dialyzed at pH 2.7 as noted above for WBC-NDV. Acid-dialyzed WBC-PHA was found to react identically to PBS-dialyzed WBC-PHA in the heat inactivation and chemical stability experiments, and was not used in the molecular weight and isoelectric focusing studies.
Preparation of IC-induced human interferon in MSF cells (MSF-IC). MSF were exposed to 10 ug of poly IC per ml and 100 Ag of DEAE-D (molecular weight 2,000,000) per ml for 3 h, washed three times, and incubated overnight in L-15 supplemented with 5% FCS. The interferon-containing medium was then harvested and stored at -80°C in 2.0-ml aliquots.
Preparation of virus-induced interferon in MSF cells (MSF-NDV). Confluent Interferon assays. Human interferon was assayed on MSF using vesicular stomatitis virus (VSV) as the challenge virus. The plaque reduction and microtiter techniques utilized were described previously (4, 19) . In such assays, interferon-treated cell monolayers are washed free oftest samples prior to virus challenge. Chicken interferon assays were performed on CEF by plaque reduction with VSV as the challenge virus (19) .
Heat inactivation. Aliquots of each interferon, containing 1,000 to 2,000 interferon units per ml, were placed in a 560C water bath. At indicated intervals (10, 20, 30, 60 , and 120 min), samples were withdrawn, placed in an ice bath, and titered immediately. Comparisons of differences in the rate of heat inactivation between the fibroblast and leukocyte interferon were performed twice. Electrofocusing. Electrofocusing was performed by the technique of Wrigley (21). Samples containing 10,000 to 80,000 interferon units were exhaustively dialyzed for 24 h against 0.05 M PBS at 40C and then mixed with appropriate amounts of catalyst solution, acrylamide solution, and carrier ampholytes. Each interferon was focused either in both the pH 5 to 8 and 3 to 10 ampholyte ranges or twice in the pH 3 to 10 range. A current of 1 mA per tube was applied in a Buchler disc electrophoresis apparatus. The voltage was maintained constant and the amperage was allowed to diminish. Electrofocusing was performed at 400 for periods ranging from 5 to 25 h. The gels were subsequently sliced into 12 to 15 equal segments, each of which wes homogenized in 0.5 ml of distilled water. After a measurement of pH and an overnight incubation at 40C, 0.2 ml of a solution containing antibiotics and 4% FCS was added to each fraction prior to assay for interferon activity. Linear pH gradients were established in all experiments.
Molecular weight determinations. Estimations of molecular weight were performed on a column of Sephadex G-200 superfine, which was extensively washed with 0.05 M PBS. The void volume was marked with dextran blue, and the column was calibrated with proteins of known molecular weight. Interferon samples containing 15,000 to 40,000 interferon units in 0.8 ml were applied to the column through a flow adaptor. The specimens were eluted using inverse flow of 0.05 M PBS at pH 7.0 in general; fractions of 0.5 ml were collected at a flow rate of 0.5 ml/h. At the completion of the run, each fraction was passed through a 300-nm membrane filter (Millipore Corp.) and titered immediately. Molecular weight estimates were made by the method of Andrews (1). Each interferon was chromatographed at least twice on Sephadex G-200 superfine. MSF-IC and WBC-NDV were also run on Sepharose 6B.
Additionally, both MSF-IC and WBC-IC interferons were acidified and chromatographed at pH 2.7 using a 0.05 M citric acid eluant on both G-200 and G-75 superfine columns.
Chemical reagents. Solutions were prepared immediately prior to use with reagent-grade chemicals. The diluent for dithiothreitol and urea was PBS containing 250 ,ug of streptomycin per ml and 150 ,ug of potassium penicillin G per ml; for iodoacetamide and sodium periodate the diluent was distilled water. Solutions of urea and iodoacetamide were sterilized by membrane filtration (Millipore Corp.). The preparation of acetic anhydride solution occurred in two steps: first, saturated sodium acetate was added to an equal volume of PBS containing the interferon to be exposed; second, acetic anhydride was added with vigorous shaking until its desired final concentration was achieved. Table 3 ) were either rendered free of extraneous ions through passage on columns of Amberlite MB-3 or purchased "free of cyanide" contamination from Schwarz-Mann.
Exposure of interferon to reagents. One-half milliliter of each interferon was mixed with a like volume of dithiothreitol, allowed to incubate under the conditions defined in Table 1 , and then diluted to the appropriate volume in L-15 medium supplemented with FCS (20 ml/100 ml), glutamine (30 ,ug/ml), arginine (90 ug/ml), glucose (1 ,lg/ml), potassium penicillin G (150 ,ug/ml), and streptomycin (250 ,ug/ ml). With all other reagents, interferon was added in 0.2-to 2.0-ml quantities to the reagent solution to make the final volume of 8 ml. When the tests were performed in microtiter, the proportions ofthe interferon reagent solutions were maintained as above, but the final volume was only 2 ml.
As a control for each test, interferon was also exposed, in the same concentration and under the same conditions, to an identical solution which lacked the test reagents. It was deemed appropriate to make an exception for the interferon control ofthe iodoacetamide test. Here, to simulate the molarity of the iodoacetamide test solution, 10 mM dextrose was added to the water diluent of the interferon control. Table 1 lists the conditions under which interferon was exposed to the various reagents.
To avert cytotoxicity by test reagents upon exposure to cell culture, test and control solutions were routinely dialyzed against 250 volumes of Geys BSS for 24 h prior to assay for interferon. Dialysis was found to be unnecessary in the case of dithiothreitol and was therefore omitted. The results reported are based on interferon assays which, in every case, were devoid of cytopathic effect due to the test reagent.
To determine if observed differences between human and chicken interferons were artifactual, mixtures containing interferon from both species were also exposed to reagent and control solutions. At the completion of such a test, interferon was assayed both on chicken and human cells.
RESULTS
Thermal sensivitity. Figure 1 type of human interferon tested was inactivated at 56°C, WBC-NDV and WBC-IC interferons were the least susceptible, both by being slowly inactivated initially and by retaining significant activity at 2 h (Table 2) . WBC-PHA was more heat labile than were the other two WBC interferons in that it resembled the fibroblast interferons in the first 30 min ofexposure but differed from the latter at 2 h time by retaining a small amount of activity (whereas the fibroblast interferons were devoid of all biological activity). Repeat testing gave similar results.
Isoelectric points. The isoelectric points (pIs) determined by peaks of interferon activity after electrofocusing can be seen in Table 2 , whereas Fig. 2 demonstrates the pattern of activity after this procedure for MSF-IC and WBC-NDV. Hunian MSF-IC had a single peak of activity with pI very close to pH 5. MSF-NDV activity resembled the MSF-IC activity, in that the majority of activity resided in a peak found close to pH 5. On the other hand, interferons derived from leukocytes had a much broader range of activity with peaks observed at both ends of the activity range. The more acid peak of the leukocyte-derived interferons induced by NDV and by IC appeared to be close to pH 5.3, whereas the more basic peak was at pH 6.9. WBC-PHA also focused over a broad pH range, with two peaks at slightly more acidic pH values than observed from the other WBC interferons. When fraction pools of WBC-NDV interferon containing the pH ranges of 6.5 to 7.0 or 5.3 to 5.7 were re-electrofocused, single peaks were then identified with pIs identical to those of the initial interferon fractions. Recovery rates for interferons during the electrofo- cusing procedure ranged from 10 to 100%, with a mean of 46%.
Molecular weight determination. When chromatography was carried out at pH 7.0, MSF-IC interferon had an estimated molecular weight of 300,000 and MSF-NDV interferon had a molecular weight of 25,000 (Table 2) . Leukocyte interferon also had a molecular weight of 25,000 when induced by NDV, but only 12,000 when induced by either IC or PHA. Both fibroblast and leukocyte interferons induced by IC were acidified to pH 2.7 and chromatographed at these lower pH ranges. Acid chromatography of MSF-IC interferon resulted in the absence of a peak at 300,000 molecular weight and in the appearance ofa peak antiviral activity at 14,000 molecular weight. Occasionally under these circumstances a second activity peak, representing up to 50% of the recovered biological activity, was detected at 25,000 molecular weight. In contrast, no change occurred in the estimated molecular weight for WBC-IC interferon when chromatographed at acid pH. Molecular weight estimations performed at pH 7 for MSF-IC and WBC-NDV and at pH 2.7 for MSF-IC are shown in Fig. 3 . Repeat runs of each of the interferons tested always gave identical results. Recovery rates following chromatography ranged from 5 to 30%, with a mean of 16%.
Chemical sensitivity. All five human interferons tested differed from chicken interferon in two major regards (Table 3) : (i) each was considerably more resistant to disulfide bond reduction with dithiothreitol, and (ii) each was more sensitive to disruption of hydrogen bonds by urea. Among the human interferons, those derived from leukocytes were relatively less sensitive to urea than those derived from fibroblasts. Furthermore, whereas the three leukocyte interferons resembled chicken interferon in being completely resistant to attack on sulfhydryl groups by iodoacetamide, both fibroblast interferons were partially inactivated by the reagent. These differences between human leukocyte and human fibroblast interferons are ANTIMICROB. AGENTS CHEMOTHER. (5) . In view of the fact that differences between interferons from different cell types involve charge, heat stability, and chemical stability (all properties dependent on molecular characteristics), we conclude that there are undoubtedly structural differences between interferons from different cells. Our hypothesis is strengthened by the recent demonstration by Havell et al. (9) of antigenic differences between fibroblast IC-and leukocyte virus-induced interferons. Nevertheless, it does appear that the inducer may exert some influence on at least one physical property, mainly molecular weight, although further investigation may show this property to be only a manifestation of dissimilar packaging. In discussing the effects of the inducer, it is important to point out that virus-induced interferons require acid dialysis to eliminate infectious particles; thus, it is necessary to ask what influence this process may have on the physicochemical properties we have reported. In considering the effects of acid dialysis on the interferon species studied here, it is important to compare the properties of the interferons induced in each cell type by viruses and by IC. In the case of virus, acid treatment was undertaken to eliminate the infectivity of the residual inducer, whereas in the case of the IC, which has no infectivity, acid treatment was unnecessary.
Although differing with respect to acid treatment, interferons induced by the two inducers in a single cell strain (either leukocytes or fibroblasts) have identical electrofocusing properties, rates of heat inactivation, and chemical stabilities. If the acid had affected these properties, the interferons induced in the same cell by different inducers might well have been dissimilar rather than similar as was observed here. The reverse argument also holds; i.e., the two acid-treated interferons (i.e., WBC-NDV and MSF-NDV) are dissimilar as are the two nonacid interferons (i.e., WBC-IC and MSF-IC). Ifthe acid treatment was responsible for all the differences observed here, these aciddialyzed interferons should have been identical as should the nonacid-dialyzed species. In the case of molecular weights, where differences exist between interferons induced in the same cell type, acid treatment could be responsible. However, if acid artifactually creates a difference where one does not exist, it would only strengthen our thesis that the cell induced is the important determinant of the properties of native interferons. b Test in which a mixture of human and chicken interferon was exposed to the treatment solutions. c Test using deionized 6 M urea.
In addition to the interferons discussed above, human leukocytes may produce a really different interferon during transformation. Thus WBC-PHA, although being identical to other leukocyte interferons in most of the parameters studied here, is significantly more sensitive to thermal inactivation than either WBC-NDV or WBC-IC interferon. We interpret this difference to indicate there are probable structural dissimilarities between WBC-PHA interferon and the other two leukocyte interferons. Considering the unique role leukocytes play in the immune system, and the large number of lymphokines already described, it would not be surprising if immune interferon were structurally different from interferon induced by leukocytes in stationary phase.
It should be noted that our estimated molecular weight of 300,000 for MSF-IC interferon is larger than a previous estimate of96, 000 (13) . Thus, the unexpected differences between human and chicken interferon reported here do have analogies in certain other mammalian species. Although Mogensen and Cantell (15) have reported human leukocyte interferon to be susceptible to the effects of mercaptoethanol, another disulfide bond-reducing agent, their conditions were more harsh than those used here and hence are not comparable to ours. We find certain differences in stability between leukocyte and fibroblast interferons. Thus, all three leukocyte-derived interferons are more resistant to hydrogen bond attack and to sulfhydryl oxidation than the fibroblast interferon.
It is clear from the information reported here that different forms of human interferon exist. Furthermore, as we have noted above, the cell type appears to be more significant than the inducing agent in determining the characteristics of the interferon produced. It is important to add that interferons derived from cells other than fibroblasts or leukocytes may be found to differ from those already described. Since human interferons do differ in size, charge, and stability, it is very likely that they will be found to differ in absorption, distribution, metabolism, and elimination in man. Furthermore, the procedures for purification and the relative yield of biologically active products will also necessarily vary. Finally, it is entirely possible that there may be found differences in biological function among these interferons. It is likely that efforts to provide a therapeutic preparation of interferon will be most productive if these differences among the interferons are clearly recognized.
